S3E10 - Hepatitis Management for Australian Clinical Exams

Welcome to Season 3 of AMC Clinical Deep Dive!

This episode deconstructs the ASHM guidelines for Hepatitis A, B, and C. Learn key diagnostic rules: why "no healthy carrier" exists in Hepatitis B, and why Hepatitis C antibody tests should never be repeated once positive (use HCV PCR instead). We cover high-yield protocols: Hepatitis A contact tracing across a 50-day window, 6-monthly hepatocellular carcinoma screening for chronic Hep B, and Direct-Acting Antiviral (DAA) cure pathways for Hep C. Differentiate acute versus chronic management, Australian vaccination rules, and essential post-exposure prophylaxis to ace your OSCE consult!

#AMCClinicalExam #ViralHepatitis #OSCE #HepatitisB #HepatitisC #HepAContactTracing #IMGAustralia #HCCScreening #HCVPCR #HBsAgManagement

Pro Tip: In your OSCE, examiners closely monitor your understanding of long-term safety and serology interpretation! Remember that no "healthy carrier" exists for Hepatitis B; all HBsAg-positive patients require ongoing monitoring and 6-monthly HCC screening if indicated. For Hepatitis C, never order a repeat antibody test if previously positive—always use HCV PCR to detect active infection or re-infection. Finally, emphasise that DAA therapy can cure Hep C, but past clearance provides zero immunity against future re-infection!

🎧 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episodes in ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Season 1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (150 clinical scenarios) have been indexed by topic, patient group, discipline, setting, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.